Inflammatory Bowel Diseases  >>  ASP3291  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASP3291 / Drais
NCT01320332: A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis

Completed
1
16
US
ASP3291, Placebo
Telsar Pharma Inc.
Ulcerative Colitis
08/11
08/11

Download Options